Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Influenza

Free Subscription 26.12.2011 2 Antiviral Res 1 Drugs 1 J Gen Virol 1 J Infect 3 J Infect Dis 3 J Virol 8 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Antiviral Res

1. IMAI K , Ogawa H, Bui VN, Inoue H, et al
   Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials.
   Antiviral Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. TARASOV SA , Zarubaev VV, Gorbunov EA, Sergeeva SA, et al
   Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.
   Antiviral Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Drugs

3. GATWOOD J , Meltzer MI, Messonnier M, Ortega-Sanchez IR, et al
   Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
   Drugs. 2012;72:35-48.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   J Gen Virol

4. TAUBER S , Ligertwood Y, Quigg-Nichol M, Dutia B, et al
   Behaviour of influenza A viruses differentially-expressing segment 2 gene products in vitro and in vivo.
   J Gen Virol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   J Infect

5. ISHII H , Komiya K, Yamagata E, Yatera K, et al
   Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection.
   J Infect. 2011.
   PubMed     Text format     Related articles   
   
   
   

   
   J Infect Dis

6. IWANE MK , Prill MM, Lu X, Miller EK, et al
   Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children.
   J Infect Dis. 2011;204:1702-10.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. SCHEPENS B , Ibanez LI, De Baets S, Hultberg A, et al
   Nanobodies(R) specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
   J Infect Dis. 2011;204:1692-701.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. GRAHAM BS
   Future opportunities for passive immunity against viral diseases.
   J Infect Dis. 2011;204:1648-50.
   PubMed     Text format     Related articles   
   
   
   

   
   J Virol

9. CHEN Z , Zhou H, Kim L, Jin H, et al
   The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.
   J Virol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. CILLONIZ C , Pantin-Jackwood MJ, Ni C, Carter VS, et al
    Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. UCHIDA Y , Watanabe C, Takemae N, Hayashi T, et al
    Identification of host genes linked with the survivability of chickens infected with recombinant viruses possessing H5N1 surface antigens from a highly pathogenic avian influenza virus.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Vaccine

12. VESIKARI T , Forsten A, Herbinger KH, Cioppa GD, et al
    Safety and immunogenicity of an MF59((R))-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. PITMAN RJ , White LJ, Sculpher M
    Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. HARDELID P , Fleming DM, Andrews N, Barley M, et al
    Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: Results from a cohort study in general practice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. GUTHMANN JP , Fonteneau L, Bonmarin I, Levy-Bruhl D, et al
    Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. MATSUSHITA M , Takeuchi S, Kumagai N, Uehara Y, et al
    Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. LERTDUMRONGLUK P , Changsirikulchai S, Limkunakul C, Prachukthum P, et al
    Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. KARRON RA , Thumar B, Schappell E, Surman S, et al
    Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. CARRARO G , Naso A, Montomoli E, Gasparini R, et al
    Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: A pilot study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Virology

20. BUI VN , Ogawa H, Xininigen, Karibe K, et al
    H4N8 subtype avian influenza virus isolated from shorebirds contains a unique PB1 gene and causes severe respiratory disease in mice.
    Virology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from www.InfluenzaWorld.com, a Roche service.

Amedeo is a Flying Publisher website.    Design: